Final Results Of Neuralstem Phase I Stem Cell Trial In ALS-Lou GehrigsDisease Published In Annals of Neurology | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
From onlinelibrary.wiley.com - March 17, 2014 4:53 PM

The US Food and Drug Administration–approved trial, “A Phase 1, Open-Label, First-in-Human, Feasibility and Safety Study of Human Spinal Cord-Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis, Protocol Number: NS2008-1,” is complete. Our overall objective was to .............